Newborn screening for homocystinuria
- PMID: 26423208
- PMCID: PMC7177267
- DOI: 10.1002/14651858.CD008840.pub4
Newborn screening for homocystinuria
Abstract
Background: Homocystinuria is a rare inherited disorder due to a deficiency in cystathionine beta synthase. Individuals with this condition appear normal at birth but develop serious complications in childhood. Diagnosis and treatment started sufficiently early in life can effectively prevent or reduce the severity of these complications. This is an update of a previously published review.
Objectives: To determine if newborn population screening for the diagnosis of homocystinuria due to cystathionine beta synthase deficiency leads to clinical benefit compared to later clinical diagnosis.
Search methods: We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group's Inborn Errors of Metabolism Trials Register.Date of the most recent search of the Inborn Errors of Metabolism Register: 08 June 2015.
Selection criteria: Randomised controlled trials and controlled clinical trials assessing the use of any neonatal screening test to diagnose infants with homocystinuria before the condition becomes clinically evident. Eligible studies compare a screened population versus a non-screened population.
Data collection and analysis: No studies were identified for inclusion in the review.
Main results: No studies were identified for inclusion in the review.
Authors' conclusions: We were unable to identify eligible studies for inclusion in this review and hence it is not possible to draw any conclusions based on controlled studies; however, we are aware of uncontrolled case-series which support the efficacy of newborn screening for homocystinuria and its early treatment. Any future randomised controlled trial would need to be both multicentre and long term in order to provide robust evidence for or against screening and to allow a cost effectiveness analysis to be undertaken.
Conflict of interest statement
John Walter: received honorariums for educational work for Recordarti Rare Diseases Foundation.
Nikki Jahnke: none known.
Tracey Remmington: none known.
Update of
-
Newborn screening for homocystinuria.Cochrane Database Syst Rev. 2013 Aug 1;(8):CD008840. doi: 10.1002/14651858.CD008840.pub3. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2015 Oct 01;(10):CD008840. doi: 10.1002/14651858.CD008840.pub4. PMID: 23908001 Updated.
References
Additional references
Aoki 2003
-
- Aoki K. Newborn screening in Japan. Southeast Asian Journal of Tropical Medicine and Public Health 2003;34(Suppl 3):80. - PubMed
Bodamer 2007
-
- Bodamer OA, Hoffmann GF, Lindner M. Expanded newborn screening in Europe. Journal of Inherited Metabolic Disease 2007;30(4):439-44. - PubMed
Burton 2010
-
- Burton H, Moorthie S (PHG Foundation). Expanded newborn screening: A review of the evidence. www.phgfoundation.org/reports/5504/ (accessed 18 November 2010).
Gan‐Schreier 2010
-
- Gan-Schreier H, Kebbewar M, Fang-Hoffmann J, Wilrich J, Abdoh G, Ben-Omran T, et al. Newborn Population Screening for Classic Homocystinuria by Determination of Total Homocysteine from Guthrie Cards. Journal of Pediatrics 2010;156(3):427-32. - PubMed
Higgins 2003
Higgins 2011a
-
- Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Higgins 2011b
-
- Higgins JPT, Deeks JJ, Altman DGonbehalfoftheCSMG. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Kaye 2006
-
- Kaye CI, Accurso F, La Franchi S, Lane PA, Hope N, Sonya P, Bradley G, Michele AL. Newborn screening fact sheets. Pediatrics 2006;118:e934-e963. - PubMed
Mudd 1985
-
- Mudd SH. Vascular disease and homocysteine metabolism. New England Journal of Medicine 1985;313(12):751-3. - PubMed
Mudd 2001
-
- Mudd SH, Levy HL, Kraus JP. Disorders of transulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors(s). The Metabolic and Molecular Bases of Inherited Disease. 8th edition. New York: McGraw Hill, 2001:2016-40.
Naughten 1998
-
- Naughten E, Yap S, Mayne PD. Newborn screening for homocystinuria: Irish and worldwide experience. European Journal of Pediatrics 1998;157(Suppl 2):S84-7. - PubMed
RevMan 2014 [Computer program]
-
- The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Skovby 2010
Walter 1998
-
- Walter JH, Wraith JE, White FJ, Bridge C, Till J. Strategies for the treatment of cystathionine beta-synthase deficiency: the experience of the Willink Biochemical Genetics Unit over the past 30 years. European Journal of Pediatrics 1998;157(Suppl 2):S71-6. - PubMed
Wilcken 2009
-
- Wilcken B, Haas M, Joy P, Wiley V, Bowling F, Carpenter K, et al. Expanded newborn screening: outcome in screened and unscreened patients at age 6 years. Pediatrics 2009;124(2):e241-e248. - PubMed
Wilson 1968
-
- Wilson JMG, Jungner G. Principles and practice of screening for disease. WHO Public Health Papers 1968;34.
References to other published versions of this review
Walter 2011
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical